Literature DB >> 21397894

Synergistic effect between clove oil and its major compounds and antibiotics against oral bacteria.

Sang-Eun Moon1, Hye-Young Kim, Jeong-Dan Cha.   

Abstract

BACKGROUND: Essential oils have been found to be antibacterial, antifungal, spasmolytic, and antiplasmodial activity and therapeutic effect in cancer treatment. OBJECTIVE AND
DESIGN: In this study, clove oil and its major compounds, eugenol and β-caryophyllene were evaluated against oral bacteria, either alone or in combination with ampicillin or gentamicin, via checkerboard and time kill assay.
RESULTS: The antibacterial activity of the clove oil was higher than β-caryophyllene but was similar to eugenol against all tested oral bacteria. Furthermore, the MIC and MBC were reduced to one half-one sixteenth as a result of the combination of clove oil or eugenol with antibiotics. The synergistic interaction was verified by time kill studies using the clove oil or eugenol with antibiotics. 60 min of treatment with MIC of the clove oil or eugenol with ampicillin or gentamicin resulted in an increase in the rate of killing in units of CFU/mL to a greater degree than was observed with alone.
CONCLUSION: The results suggest that the clove oil and eugenol could be employed as a natural antibacterial agent against cariogenic and periodontopathogenic bacteria.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21397894     DOI: 10.1016/j.archoralbio.2011.02.005

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  23 in total

Review 1.  Strategic Moves of "Superbugs" Against Available Chemical Scaffolds: Signaling, Regulation, and Challenges.

Authors:  Bikash Baral; M R Mozafari
Journal:  ACS Pharmacol Transl Sci       Date:  2020-04-13

2.  Assessment of antifungal activity of herbal and conventional toothpastes against clinical isolates of Candida albicans.

Authors:  Ghaleb Adwan; Yousef Salameh; Kamel Adwan; Ali Barakat
Journal:  Asian Pac J Trop Biomed       Date:  2012-05

3.  Antimicrobial Activity of the Essential Oil of Plectranthus neochilus against Cariogenic Bacteria.

Authors:  Eduardo José Crevelin; Soraya Carolina Caixeta; Herbert Júnior Dias; Milton Groppo; Wilson Roberto Cunha; Carlos Henrique Gomes Martins; Antônio Eduardo Miller Crotti
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-16       Impact factor: 2.629

4.  Eugenol: a phyto-compound effective against methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical strain biofilms.

Authors:  Mukesh Kumar Yadav; Sung-Won Chae; Gi Jung Im; Jae-Woo Chung; Jae-Jun Song
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

Review 5.  Multimodal management of dental pain with focus on alternative medicine: A novel herbal dental gel.

Authors:  A Kumarswamy
Journal:  Contemp Clin Dent       Date:  2016 Apr-Jun

Review 6.  Essential Oils and Their Components as Modulators of Antibiotic Activity against Gram-Negative Bacteria.

Authors:  Petruta Aelenei; Anca Miron; Adriana Trifan; Alexandra Bujor; Elvira Gille; Ana Clara Aprotosoaie
Journal:  Medicines (Basel)       Date:  2016-07-28

Review 7.  Antimicrobial Activity of Some Essential Oils-Present Status and Future Perspectives.

Authors:  Sonam Chouhan; Kanika Sharma; Sanjay Guleria
Journal:  Medicines (Basel)       Date:  2017-08-08

Review 8.  Antioxidant Activity of Spices and Their Impact on Human Health: A Review.

Authors:  Alexander Yashin; Yakov Yashin; Xiaoyan Xia; Boris Nemzer
Journal:  Antioxidants (Basel)       Date:  2017-09-15

Review 9.  Porphyromonas gingivalis: where do we stand in our battle against this oral pathogen?

Authors:  Kaitlind C Howard; Octavio A Gonzalez; Sylvie Garneau-Tsodikova
Journal:  RSC Med Chem       Date:  2021-02-26

10.  Honey - a potential agent against Porphyromonas gingivalis: an in vitro study.

Authors:  Sigrun Eick; Gesine Schäfer; Jakub Kwieciński; Julia Atrott; Thomas Henle; Wolfgang Pfister
Journal:  BMC Oral Health       Date:  2014-03-25       Impact factor: 2.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.